BIIB Insider Transactions — Page 6
1,530 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| PICKETT CECIL B | President, R & D | 2008-07-22 | Sale | 9,054.0 | $70.0 |
| PICKETT CECIL B | President, R & D | 2008-07-22 | Sale | 5,000.0 | $69.0 |
| MacLean Michael F | SVP, Chief Accounting Officer | 2008-07-22 | Sale | 682.0 | $70.0 |
| HASLER HANS PETER | EVP, Global Neurology, Int'l | 2008-07-22 | Sale | 12,950.0 | $69.31 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-07-22 | Sale | 156,086.0 | $70.0 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-07-22 | Sale | 6,485.0 | $71.5 |
| ALEXANDER SUSAN H | EVP, General Counsel | 2008-07-22 | Sale | 2,000.0 | $70.0 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-07-21 | Sale | 6,485.0 | $67.5 |
| SHARP PHILIP A | Director | 2008-07-21 | Sale | 72,500.0 | $68.0 |
| WIGGINS MARK C | EVP Corp. and Bus. Dev. | 2008-07-15 | Sale | 6,250.0 | $64.0 |
| Hasnain Faheem | EVP, Oncology/Rheumatology SBU | 2008-07-09 | Sale | 15,800.0 | $62.56 |
| Hasnain Faheem | EVP, Oncology/Rheumatology SBU | 2008-07-09 | Sale | 21,037.0 | $61.71 |
| ALEXANDER SUSAN H | EVP, General Counsel | 2008-07-08 | Sale | 8,599.0 | $60.0 |
| Clancy Paul J | CFO | 2008-07-01 | Sale | 4,208.0 | $56.01 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 20.0 | $62.12 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 20.0 | $62.11 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 400.0 | $62.03 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 200.0 | $62.0 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 200.0 | $61.67 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 100.0 | $61.5 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 100.0 | $61.49 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 100.0 | $61.14 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 200.0 | $61.09 |
| ROSS BRUCE | Director | 2008-06-04 | Sale | 500.0 | $61.07 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $62.24 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $62.0 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.87 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.83 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 500.0 | $61.79 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.78 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 400.0 | $61.77 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.76 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 400.0 | $61.74 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 1,400.0 | $61.73 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.7 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.69 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.68 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 600.0 | $61.67 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 700.0 | $61.66 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 100.0 | $61.64 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 800.0 | $61.57 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 400.0 | $61.51 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 600.0 | $61.5 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.49 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 100.0 | $61.48 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.47 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.45 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.4 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.39 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 100.0 | $61.35 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 200.0 | $61.32 |
| GLASSBERG ALAN | Director | 2008-04-29 | Sale | 300.0 | $61.28 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 400.0 | $64.23 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 13.0 | $64.22 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 3.0 | $64.13 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $64.09 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 297.0 | $64.07 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 400.0 | $63.95 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $63.87 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $63.8 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $63.79 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 700.0 | $63.75 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 200.0 | $63.72 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 200.0 | $63.7 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 200.0 | $63.55 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $63.54 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 200.0 | $63.51 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 200.0 | $63.49 |
| Hamm Robert A | EVP, Pharma. Oper. & Tech. | 2008-04-15 | Sale | 100.0 | $63.48 |
| MULLEN JAMES C | CEO & President | 2008-04-15 | Sale | 12,800.0 | $64.95 |
| MULLEN JAMES C | CEO & President | 2008-04-14 | Sale | 200.0 | $64.95 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 300.0 | $64.34 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 100.0 | $64.31 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 600.0 | $64.29 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 200.0 | $64.27 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 100.0 | $64.24 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 300.0 | $64.23 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 200.0 | $64.19 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 400.0 | $64.12 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 300.0 | $64.1 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 500.0 | $64.09 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 12.0 | $64.07 |
| DUNN JOHN MICHAEL | EVP, New Ventures | 2008-04-14 | Sale | 200.0 | $64.06 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 27,593.0 | $65.01 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 800.0 | $65.69 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 400.0 | $65.61 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 400.0 | $65.56 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 11,600.0 | $65.5 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 100.0 | $65.47 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 200.0 | $65.45 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 600.0 | $65.44 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 56.0 | $65.42 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 2,700.0 | $65.4 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 1,100.0 | $65.39 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 1,282.0 | $65.37 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 1,007.0 | $65.34 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 340.0 | $65.33 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 53.0 | $65.32 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 1,723.0 | $65.31 |
| MULLEN JAMES C | CEO & President | 2008-04-11 | Sale | 1,356.0 | $65.3 |